Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
- PMID: 3422148
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Abstract
This report of an expert panel of the National Cholesterol Education Program provides new guidelines for the treatment of high blood cholesterol in adults 20 years of age and over. Total cholesterol levels are classified as follows: less than 200 mg/dL--"desirable blood cholesterol"; 200 to 239 mg/dL--borderline-high blood cholesterol; greater than or equal to 240 mg/dL--high blood cholesterol. The guidelines detail which patients should go on to have lipoprotein analysis, and which should receive cholesterol-lowering treatment on the basis of their low density lipoprotein (LDL)-cholesterol levels and status with respect to other coronary heart disease risk factors. Dietary therapy is the primary cholesterol-lowering treatment. The report specifies the LDL-cholesterol levels at which dietary therapy should be started and the goals of therapy, and provides detailed guidance on the nature of the recommended dietary changes. If, after six months of intensive dietary therapy, LDL-cholesterol exceeds specified levels, drug treatment should be considered.
Comment in
-
The place of HDL in cholesterol management. A perspective from the National Cholesterol Educational Program.Arch Intern Med. 1989 Mar;149(3):505-10. Arch Intern Med. 1989. PMID: 2645842 Review.
-
A critique of the report of the National Institutes of Health Expert Panel on detection, evaluation, and treatment of high blood cholesterol.Arch Intern Med. 1989 Jul;149(7):1501-3. Arch Intern Med. 1989. PMID: 2742421
Similar articles
-
The National Cholesterol Education Program: implications for dietetic practitioners from the Adult Treatment Panel recommendations.J Am Diet Assoc. 1988 Nov;88(11):1401-8, 1411. J Am Diet Assoc. 1988. PMID: 3183260
-
Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.J Heart Lung Transplant. 1995 Jul-Aug;14(4):613-22. J Heart Lung Transplant. 1995. PMID: 7578166 Clinical Trial.
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. doi: 10.1016/j.jacc.2004.07.001. J Am Coll Cardiol. 2004. PMID: 15358046 Review.
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. doi: 10.1161/01.ATV.0000133317.49796.0E. Arterioscler Thromb Vasc Biol. 2004. PMID: 15297292 Review.
-
Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.Clin Ther. 2004 Nov;26(11):1821-33. doi: 10.1016/j.clinthera.2004.11.015. Clin Ther. 2004. PMID: 15639694 Clinical Trial.
Cited by
-
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine.Chem Rev. 2024 Oct 23;124(20):11242-11347. doi: 10.1021/acs.chemrev.4c00244. Epub 2024 Oct 8. Chem Rev. 2024. PMID: 39380213 Free PMC article. Review.
-
Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up.Lipids Health Dis. 2024 Sep 28;23(1):320. doi: 10.1186/s12944-024-02302-x. Lipids Health Dis. 2024. PMID: 39342373 Free PMC article.
-
High serum Cholesterol and Triglyceride levels in older adults: associations with sleep and nighttime behavior disorders at baseline and a prediction analysis of incidental cases at 12 months follow-up.medRxiv [Preprint]. 2024 Jun 6:2024.06.05.24308529. doi: 10.1101/2024.06.05.24308529. medRxiv. 2024. Update in: Lipids Health Dis. 2024 Sep 28;23(1):320. doi: 10.1186/s12944-024-02302-x. PMID: 38883726 Free PMC article. Updated. Preprint.
-
Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?J Clin Med. 2023 Sep 3;12(17):5737. doi: 10.3390/jcm12175737. J Clin Med. 2023. PMID: 37685804 Free PMC article. Review.
-
Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States.Ann Intern Med. 2023 Aug;176(8):1057-1066. doi: 10.7326/M23-0720. Epub 2023 Jul 25. Ann Intern Med. 2023. PMID: 37487210 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
